Visual outcome in Japanese patients with Acanthamoeba keratitis

Eye

Volumn 26, Issue 4, 2012, Pages 517-522

  Yamazoe, K ^a,b   Yamamoto, Y ^a   Shimazaki Den, S ^a   Shimazaki, J ^a,c  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Acanthamoeba; chlorhexidine gluconate; keratitis; keratoplasty

Indexed keywords

ACICLOVIR; CEFMENOXIME; CHLORHEXIDINE GLUCONATE; FLUCONAZOLE; GATIFLOXACIN; LEVOFLOXACIN; MICAFUNGIN; MICONAZOLE NITRATE; MOXIFLOXACIN; OFLOXACIN; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE ISETHIONATE; STEROID; TOSUFLOXACIN TOSILATE;

ACANTHAMOEBA KERATITIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; JAPANESE; KERATOPLASTY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALIDITY; PROGNOSIS; VISION; VISUAL ACUITY;

EID: 84859777756     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.366     Document Type: Article

References (18)

1. Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. Br J Ophthalmol 1998; 82: 1387-1392.
2. Joslin CE, Tu EY, McMahon TT, Passaro DJ, Stayner LT, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol 2006; 142: 212-217.
3. Sun X, Zhang Y, Li R, Wang Z, Luo S, Gao M et al. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology 2006; 113: 412-416.
4. Thebpatiphat N, Hammersmith KM, Rocha FN, Rapuano CJ, Ayres BD, Laibson PR et al. Acanthamoeba keratitis: a parasite on the rise. Cornea 2007; 26: 701-706.
5. Por YM, Mehta JS, Chua JL, Koh TH, Khor WB, Fong AC et al. Acanthamoeba keratitis associated with contact lens wear in Singapore. Am J Ophthalmol 2009; 148: 7.e2-12.e2.
6. Butler TK, Males JJ, Robinson LP, Wechsler AW, Sutton GL, Cheng J et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clin Experiment Ophthalmol 2005; 33: 41-46.
7. Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L et al. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997; 104: 1587-1592.
8. Radford CF, Minassian DC, Dart JK. Acnthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 2002; 86: 536-542.
9. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009; 148: 487.e2-499.e2.
10. Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol 2008; 145: 130-135.
11. Kosrirukvongs P, Wanachiwanawin D, Visvesvara GS. Treatment of acanthamoeba keratitis with chlorhexidine. Ophthalmology 1999; 106: 798-802.
12. Tu EY, Joslin CE, Sugar J, Schoff ME, Booton GC. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology 2008; 115: 1998-2003.
13. Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol 2004; 242: 648-653.
14. Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995; 79: 1078-1082.
15. Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 1993; 100: 1238-1243.
16. Brooks Jr JG, Coster DJ, Badenoch PR. Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea 1994; 13: 186-189.
17. Kitzmann AS, Goins KM, Sutphin JE, Wagoner MD. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 2009; 116: 864-869.
18. Ficker LA, Kirkness C, Wright P. Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 1993; 100: 105-110.